• Home
  • Pipeline
    • Inhaled Murepavadin
    • Balixafortide
    • Lonodelestat (external)
  • Breakthrough Platforms
  • Partnering
  • About us
  • Investor Relations
    • Corporate Governance*
    • Reporting*
    • Corporate Presentation
    • Share Information
    • Media Releases
    • Ad-hoc Releases
    • Calendar
    • Contact
  • Careers
  • Contact
    • Home
    • Pipeline
      • Inhaled Murepavadin
      • Balixafortide
      • Lonodelestat (external)
    • Breakthrough Platforms
    • Partnering
    • About us
    • Investor Relations
      • Corporate Governance*
      • Reporting*
      • Corporate Presentation
      • Share Information
      • Media Releases
      • Ad-hoc Releases
      • Calendar
      • Contact
    • Careers
    • Contact
    Spexis
    Spexis
    News
    Menu
    • Home
    • Pipeline
      • Inhaled Murepavadin
      • Balixafortide
      • Lonodelestat (external)
    • Breakthrough Platforms
    • Partnering
    • About us
    • Investor Relations
      • Corporate Governance*
      • Reporting*
      • Corporate Presentation
      • Share Information
      • Media Releases
      • Ad-hoc Releases
      • Calendar
      • Contact
    • Careers
    • Contact
    News
    Menu
    • Nov152018

      November 13, 2018: Polyphor wins the 2018 Lifestars Awards in the category “EU CAPITAL MARKET TRANSACTION OF THE YEAR”

      This award recognizes not only the achievement of an impactful and transformational IPO on the public markets, but also the…

      Spexis
      Alexandre Müller
    • Feb142018

      June 10–14, 2018: Bacterial Persistence and Antimicrobial Therapy, Ascona, Switzerland

      June 13, 2018 – 17:30 – 18:00: Technology and Innovative Treatment Strategies

      Spexis
      raskin
    • Feb142018

      June 6-9, 2018: 41st European Cystic Fibrosis Conference (ECFS), Belgrad, Serbia

      Meet our scientists for exchange.

      Spexis
      raskin
    • Feb142018

      June 1-5, 2018: ASCO, Chicago, US

      Meet our scientists for exchange.

      Spexis
      raskin
    • Feb142018

      April 21 – 24, 2018: ECCMID, Madrid, Spain

      Meet our scientists for exchange. Anatol Luther, Ph.D., Oral Presentation, April 21, 16.30 – 16.40 h see session: Hall L…

      Spexis
      raskin
    • 1
    • 2
    • 3
    • 4
    • Next

    News

    • Media releases
    • Ad-hoc releases
    • Conferences & events
    • Publications

    Interact with us

    • Partnering
    • Get our news
    • Join our team

     

    • Contact
    • +41 61 567 16 00
    © 2025, Spexis Ltd., Hegenheimermattweg 125, 4123 Allschwil, Switzerland, T: +41 61 567 16 00, info@spexisbio.com – Disclaimer – Privacy Rules – Disclosure
    This site uses cookies: Find out more.